CureVac and MD Anderson Partner to Develop Cancer Vaccines
By merging CureVac’s end-to-end capabilities in cancer antigen discovery and mRNA design with MD Anderson’s expertise in the same field and clinical research, the collaboration aims to develop unique cancer vaccines for hematological and solid tumor …